Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia.
暂无分享,去创建一个
C. Craddock | K. Piper | S. Siddique | J. Byrne | J. Goldman | M. Griffiths | J. Apperley | J. Perz | S. Avery | D. O’Shea | A. Lennard | E. Olavarría | L. Pallan | J. Arrazi | Julie Arrazi